ESTRO

The official page of the European Society for Radiotherapy and Oncology (ESTRO a.i.s.b.l.). VAT: BE 0432.894.370
(1)

27/03/2026

📢Late-breaking abstract submissions are now open for ESTRO 2026
Do you have new results or breakthrough data that couldn’t be submitted earlier?

Late-breaking abstracts offer a unique opportunity to present the latest, high-impact research and ensure your findings are part of the scientific programme.

📅 Submission deadline: 8 April
📍 15–19 May 2026 | Stockholm, Sweden

👉 Submit your late-breaking abstract today and showcase your latest work at : https://bit.ly/4dHoavG

26/03/2026

🗳️ ESTRO Board Elections
4️⃣ candidates. 2️⃣ positions. 1️⃣ opportunity to shape the future of ESTRO.
📅 Voting opens 7 April!
👉 Read the full profiles of the candidates and get ready to cast your vote: https://shorturl.at/iSIVy

26/03/2026

📣 Just published in the Green Journal: ESTRO’s principles for environmental sustainability in the radiation oncology community
👉 https://bit.ly/47pc0nr

24/03/2026

🧱 Building the Future of Education
Yesterday, the ESTRO Education Council came together for an interactive LEGO® workshop to reimagine the future of the ESTRO School.

💡 Through hands-on collaboration, participants built and shared models of a “School of the Future,” exploring innovative approaches to training content, formats, and technologies.

🙏 A special thank you to our facilitators, Stylianos Filopoulos (Association by Design – ABD) and Robert Rasmussen, for expertly guiding this creative and forward-thinking process. 🚀

24/03/2026

🌟 What will success look like at the end of an ESTRO presidency?
Our President-Elect candidates share their vision in 30 seconds: the impact they aim to make, and how they plan to advance ESTRO’s mission for patients and professionals alike.
🎥 Watch Carmen’s reflection and see how she envisions leading ESTRO forward.

24/03/2026

🌟 What will success look like at the end of an ESTRO presidency?
Our President-Elect candidates share their vision in 30 seconds: the impact they aim to make, and how they plan to advance ESTRO’s mission for patients and professionals alike.
🎥 Watch Hans’ reflection and see how he envisions leading ESTRO forward.

24/03/2026

📢 Join us next week to Discover the latest innovations in reirradiation planning in our upcoming webinar: “Planning Innovations in Reirradiation: Industry Technology Showcase”

📅 30 March 2026 | ⏰ 15:00 CEST | Reirradiation Focus Group | Online

In this 60-minute session, explore how emerging technologies are helping overcome key clinical and technical challenges in reirradiation.

🔍 What to expect:
✅Industry-led insights on cutting-edge technology solutions
✅Expert-led moderated discussion
✅Live Q&A with specialists in the field

🗣️ Featuring speakers from industry and moderated by leading experts:
- Stina Svensson, Senior Research Engineer, PhD, RaySearch Laboratories AB
- Margaret (Mags) Carroll, Clinical Success Manager, HCPC-registered Clinical Scientist

*Speakers represent industry organisations presenting technologies relevant to reirradiation. Participation does not constitute endorsement by ESTRO of any specific technology or product.

👉 Secure your spot now and stay at the forefront of innovation in radiation oncology: https://bit.ly/4t8ML16
🔗 Series overview: https://bit.ly/3JuqEkg

24/03/2026

📢 Happening today – don’t miss out!
Join our Pre-course Webinar on Adaptive Radiotherapy today from 15:00–16:00 CET and explore the latest clinical advances, emerging evidence, and real-world implementation of adaptive radiotherapy.

🔵 MRI-, CBCT-, and proton-based developments
🔵 Growing clinical experience
🔵 Why it’s ready for broader use

🔗 Secure your spot now: https://bit.ly/4b45ip5

23/03/2026

🎓 As we celebrate the 20th anniversary of the ESTRO School in 2026, we are proud to launch a special series. Over the coming weeks, we will mark this milestone through the voices of past and current leadership who have shaped the School. 🌟
💬Through their reflections, you will discover how the ESTRO School has grown into a global community, one built on shared knowledge, mentorship, and a commitment to advancing radiotherapy education worldwide. 🌍
👉 Read the full introduction by Luca Boldrini here: https://bit.ly/47gWIkx

21/03/2026

🙏 Thank you to everyone who attended and contributed to !

From inspiring scientific sessions to meaningful discussions and collaborations, your participation made this congress a true success.

We are grateful to all speakers, authors, chairs, partners, and attendees for advancing the field of head & neck oncology together.

We look forward to seeing you again at future editions!

21/03/2026

🎉 We are proud to have awarded two outstanding contributions at !
🏆 Best Paper Award: Marc Oliva Bernal
REALKEY study: patient-reported outcomes in recurrent/metastatic head and neck cancer treated with first-line immunotherapy +/- chemotherapy
🏆 Best Poster Award: Gema Bruixola
ctDNA clearance after induction therapy as a predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer
👏 Congratulations to both for their excellent work advancing research in head & neck cancer!
You can view the papers in the abstract book: https://bit.ly/4sXElt9

Adres

Avenue Marnix 17
Brussels
1000

Website

http://www.estro.org/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer ESTRO nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.